Ridgeback Biotherapeutics and DRIVE to develop Covid-19 drug

Ridgeback Biotherapeutics and the nonprofit Drug Innovations at Emory (DRIVE) at Emory University have collaborated on developing a drug candidate that could treat Covid-19.

The partners want to move EIDD-2801 from DRIVE into human clinical trials.

An oral bioavailable form of a ribonucleoside analogue that prevents the replication of various RNA viruses, including SARS-CoV2, is EIDD-2801.

Under the partnership, Ridgeback acquired a selective permit for EIDD-2801 and will propel the competitor through clinical improvement to make it accessible for the continuous pandemic.

George Painter, CEO of Drive, stated: We immediately recognized that EIDD-2801 had could potentially treat Covid-19 due to its activity against the SARS and MERS coronaviruses and its imity to influenza clinical trials. We believe that EIDD-2801 will be effective in treating people who have contracted Covid-19 based on our extensive testing.



"We are confident that Ridgeback can quickly advance EIDD-2801 into clinical trials for Covid-19 and initiate steps toward ensuring a rapid development path for this promising drug," according to Ridgeback Biotherapeutics. "Given Ridgeback Biotherapeutics' experience in accelerating the development of potential therapeutics in outbreak settings and its proven commitment to global health," Ridgeback Biotherapeutics states.

To treat coronavirus, influenza, chikungunya, and the Venezuela Healthcare Market Equine Encephalitis Virus, EIDD-2801 has been entirely or partially supported by the National Institute of Allergy and Infectious Diseases (NIAID) and the Defense Threat Reduction Agency (DTRA).

Comments

Post a Comment

Popular posts from this blog

Exploring Ecopetrol's Key Locations: A Comprehensive Guide

  Ecopetrol SA, a name synonymous with energy and innovation, stands as one of the largest integrated oil companies in Latin America. Understanding its diverse locations and operations is crucial for grasping its global impact and strategic significance. This article delves into the comprehensive details of Ecopetrol's geographical footprint , operational excellence, and its role in shaping the energy sector. To know about the assumptions considered for the study, Download for Free Sample Report Company Background History of Ecopetrol Founded in 1951, Ecopetrol has grown from a national enterprise to a global energy powerhouse. Initially focused on domestic oil extraction, the company has since expanded its horizons, embracing new technologies and markets. Mission and Vision Ecopetrol's mission revolves around sustainable growth, innovation, and value creation for its stakeholders. Its vision aims at being a leading company in the global energy transition, emphasizi...
Read more

Understanding the Competitive Landscape of BlackBerry Ltd.

  BlackBerry Ltd., once a pioneer in mobile communication, has transformed into a global leader in cybersecurity, software, and the Internet of Things (IoT). As the company navigates this new direction, it faces competition from some of the biggest names in technology. This article dives deep into the competitive landscape of BlackBerry Ltd. , highlighting the major players in the industry and how BlackBerry continues to innovate and remain relevant in a rapidly evolving market. To know about the assumptions considered for the study, Download for Free Sample Report The Evolution of BlackBerry Ltd. Founded in 1984, BlackBerry Ltd. gained global recognition for its revolutionary smartphones, which became a symbol of business and government communication. However, the shift in the mobile industry, driven by the rise of iOS and Android platforms, forced BlackBerry to pivot its business model. Today, BlackBerry focuses on enterprise software, cybersecurity, and IoT, providing solutions ...
Read more

Understanding Aflac's Growth: A Financial Analysis of the Last Quarter

  Aflac Inc., a major player in the insurance industry, is recognized globally for its extensive range of insurance products. As a Fortune 500 company, Aflac's financial health is a crucial topic for investors, stakeholders, and potential customers alike. In this detailed analysis, we delve into Aflac Inc.'s financial performance, exploring key metrics, recent trends, and future projections that could influence its market position. Please see the research report summary for a more in-depth company profile analysis . Company Background Founded in 1955, Aflac Inc. has grown to become a leader in supplemental insurance in the United States and Japan. The company’s commitment to innovation and customer service has earned it a solid reputation and a strong financial standing. Aflac’s business model focuses on providing financial protection to policyholders, primarily through supplemental health and life insurance products. This focus has allowed Aflac to maintain consistent ...
Read more